Gen-Probe Inc.
10210 Genetic Center Drive
San Diego,
CA 92121
United States - Map
Phone: 858-410-8000
Fax: 858-410-8625
Web Site: http://www.gen-probe.com
| Gen-Probe Incorporated develops, manufactures, and markets nucleic acid probe-based products used for the clinical diagnosis of human diseases, and for screening donated human blood in North America and internationally. The company develops nucleic acid testing that enables detection of microorganisms. It markets a portfolio of products that use technologies to detect various infectious microorganisms, including those causing sexually transmitted diseases, tuberculosis, strep throat, pneumonia, and fungal infections. The company also offers blood screening products for the simultaneous detection of human immunodeficiency virus (type 1), hepatitis C virus, and procleix west nile virus. In addition, it sells TIGRIS instrument that enables blood collection centers to test donors blood. Further, the company develops and manufactures nucleic acid probe-based products for the detection of harmful organisms in the environment and in industrial processes. It markets and sells its clinical diagnostic products through distributors and direct sales force, as well as other products through collaborative partners. The companys customers include reference laboratories, public health institutions, and hospitals. It has a collaboration agreement with Novartis Vaccines and Diagnostics, Inc. for the research, development, and manufacturing of its blood screening products. Gen-Probe Incorporated was founded in 1983 and is based in San Diego, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Carl W. Hull , 50
Chief Exec. Officer, Pres |
$
924.00K |
$
0 | Mr. Herm Rosenman M.B.A., C.P.A., 61
Chief Financial Officer, Principal Accounting Officer and Sr. VP of Fin. |
$
472.00K |
$
864.00K | Mr. R. William Bowen , 56
Sr. VP, Sec. and Gen. Counsel |
$
480.00K |
$
201.00K | Dr. Daniel L. Kacian Ph.D, M.D, 63
Chief Scientist and Exec. VP |
$
563.00K |
$
0 | Mr. Ben Matzilevich ,
Pres |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.16% Nasdaq 
0.02 (0.05%) 
Profile
